The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharma firms are also big beneficiaries when the rupee weakens. To ...
No other corporate actions details are available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback